Baxter International Inc. (BAX) Updates FY13 Earnings Guidance
Baxter International Inc. (NYSE:BAX) updated its FY13 earnings guidance on Thursday. The company provided earnings per share guidance of $4.65-4.67 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.67, Analyst Ratings Net reports. The company issued revenue guidance of $15.04 billion, compared to the consensus revenue estimate of $15.24 billion.Baxter International also updated its Q4 guidance to $1.24-1.26 EPS.
Baxter International Inc. (NYSE:BAX) opened at 67.56 on Thursday. Baxter International Inc. has a 52-week low of $60.81 and a 52-week high of $74.60. The stock’s 50-day moving average is $68.56 and its 200-day moving average is $70.51. The company has a market cap of $36.671 billion and a P/E ratio of 16.86.
Baxter International (NYSE:BAX) last announced its earnings results on Thursday, October 17th. The company reported $1.19 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.19. The company had revenue of $3.80 billion for the quarter, compared to the consensus estimate of $3.82 billion. During the same quarter in the previous year, the company posted $1.14 earnings per share. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. Analysts expect that Baxter International Inc. will post $4.67 EPS for the current fiscal year.
A number of research firms have recently commented on BAX. Analysts at Citigroup Inc. reiterated a neutral rating on shares of Baxter International in a research note to investors on Monday. They now have a $70.00 price target on the stock, down previously from $75.00. On a related note, analysts at JPMorgan Chase & Co. reiterated a hold rating on shares of Baxter International in a research note to investors on Friday, October 4th. They now have a $76.00 price target on the stock. Finally, analysts at RBC Capital cut their price target on shares of Baxter International from $77.00 to $73.00 in a research note to investors on Friday, October 4th. They now have an outperform rating on the stock. Six research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the stock. Baxter International presently has an average rating of Buy and an average price target of $76.38.
Baxter International Inc (NYSE:BAX) is a global, diversified healthcare company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.